GSK343 induces programmed cell death through the inhibition of EZH2 and FBP1 in osteosarcoma cells

Enhancer of zeste homolog 2 (EZH2) is an important member of the epigenetic regulatory factor polycomb group proteins (PcG) and is abnormally expressed in a wide variety of tumors, including osteosarcoma. Scientists consider EZH2 as an attractive target for the treatment of osteosarcoma and have fou...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancer Biol Ther
Main Authors: Xiong, Xifeng, Zhang, Jinli, Li, Aiguo, Dai, Libing, Qin, Shengnan, Wang, Pengzhen, Liu, Wei, Zhang, Zhi, Li, Xiaojian, Liu, Zhihe
格式: Artigo
語言:Inglês
出版: Taylor & Francis 2019
主題:
Research Paper
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7012145/
https://ncbi.nlm.nih.gov/pubmed/31651209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2019.1680061
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍